[Cite as http://purl.org/au-research/grants/nhmrc/1140406]
Brief description This project will determine if new immune inhibitory checkpoints can be synergistically targeted with BRAFV600E inhibition to reactivate and allow NK cells to maximise their anti-tumour immune functions and prevent cancer spread. It is a completely novel approach that will allow for the more rational design of melanoma treatments that targets NK cells following surgery and local radiotherapy and/or chemotherapy.
Funding Amount $AUD 450,647.26
Funding Scheme Project Grants
New Investigator Grant